Quick Answer
Rice Protein Muscle Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,].
Key Takeaways
- 01Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,]. [Lin Che-Li (2026)]
- 0212 13 14 15 16 17 18 19 20 The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults [,]. [Lin Che-Li (2026)]
- 03As a result, numerous authors have emphasized the need for a comprehensive tool that could assist with the diagnosis or the assessment of sarcopenia risk factors [,,]. [Lin Che-Li (2026)]
- 041 2 3 4 5 6 7 8 9 10 11 Sarcopenia has been recognized as a skeletal muscle disease commonly derived from aging-induced muscle degeneration, including the loss of muscle mass and morphological changes [,]. [Lin Che-Li (2026)]
The current Migaku evidence database contains 2 reusable source documents for Rice Protein Muscle Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,]. [Lin Che-Li (2026); evidence level 1]
- 12 13 14 15 16 17 18 19 20 The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults [,]. [Lin Che-Li (2026); evidence level 1]
- As a result, numerous authors have emphasized the need for a comprehensive tool that could assist with the diagnosis or the assessment of sarcopenia risk factors [,,]. [Lin Che-Li (2026); evidence level 1]
- 1 2 3 4 5 6 7 8 9 10 11 Sarcopenia has been recognized as a skeletal muscle disease commonly derived from aging-induced muscle degeneration, including the loss of muscle mass and morphological changes [,]. [Lin Che-Li (2026); evidence level 1]
- Purpose of review Resistant starch (RS) has been widely investigated as a dietary component with potential metabolic benefits, including improved insulin sensitivity, lipid profile, and inflammatory markers. [Tavares IRG (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Explore the Optimal Treatment Regimen Across Combinations of Variate Protein Sources and Exercise Modalities and Its Associated Factors in Older Adults: A Network Meta-Analysis and Meta-Regression of Randomized Controlled Trials
- Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review.